Group 1 - The company, Chaoyue Eye Care (02219), announced a share buyback plan on January 22, 2026, involving an expenditure of HKD 163,300 to repurchase 60,000 shares [1] - The buyback price per share is set between HKD 2.69 and HKD 2.75 [1]

Group 1 - The company, Chaoyujian Ophthalmology (02219), announced a share buyback plan on January 22, 2026, involving an expenditure of HKD 163,300 to repurchase 60,000 shares [1] - The buyback price per share is set between HKD 2.69 and HKD 2.75 [1]

Group 1 - The company, Chaoyue Eye Care (02219.HK), announced a share buyback on January 22, spending HKD 163,000 to repurchase 60,000 shares at a price range of HKD 2.69 to HKD 2.75 per share [1]

FF305 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02219 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的 ...

朝聚眼科(02219)发布公告，于2026年1月20日该公司斥资16.06万港元回购6万股，回购价格为每股2.64- 2.70港元。 ...

Core Viewpoint - The company, Chaoyujian Ophthalmology (02219), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Buyback Details - The company will repurchase 60,000 shares at a total cost of HKD 160,600 [1] - The buyback price ranges from HKD 2.64 to HKD 2.70 per share [1] - The buyback is scheduled for January 20, 2026 [1]

格隆汇1月20日丨朝聚眼科(02219.HK)公告，1月20日耗资16.1万港元回购6万股，每股回购价2.64-2.7港 元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 朝聚眼科醫療控股有限公司 呈交日期： 2026年1月20日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02219 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 佔有關事件前的現有已發 | | | 每股發行/出售價 (註4) | 已發行股份 ...

Core Viewpoint - The company, Chaoyue Eye Care (02219), announced a share buyback plan, intending to repurchase 60,000 shares at a cost of approximately HKD 158,900 on January 15, 2026 [1] Group 1 - The total expenditure for the share buyback is approximately HKD 158,900 [1] - The number of shares to be repurchased is 60,000 [1] - The date of the planned buyback is set for January 15, 2026 [1]

Group 1 - The company, Chaoyujian Ophthalmology (02219), announced a share buyback plan, intending to repurchase 60,000 shares at a cost of approximately HKD 158,900 on January 15, 2026 [1]